Abstract:The enzyme FabH catalyzes the initial step of fatty acid biosynthesis that is essential for bacterial survival. Therefore, FabH has been identified as an attractive target for the development of new antibacterial agents. We present here the discovery of a promising new series of Pyrazol-Benzimidazole amides with low toxicity and potent FabH inhibitory. Twenty-seven novel compounds have been synthesized, and all the compounds were characterized by H-1 NMR, C-13 NMR and MS. Afterwards they were evaluated for in vitro antibacterial activities against E. coli, P. aeruginosa, B. subtilis and S. aureus, along with E. coli FabH inhibition and cytotoxicity test. Some compounds proved to be of low toxicity and potent, especially compound 31 exhibited the most potential to be a new drug with MIC of 0.49-0.98 mu g/mL against the tested bacterial strains and IC50 of 1.22 mu M against E. coli FabH. Eight analogues 16, 28, 30, 31, 33, 34, 35 and 36 with low range MIC against wild type Xanthomonas Campestris exhibited no inhibition against FabH-deficient mutant strain, which firmly proved the class of compounds arrived at antibacterial activity via interacting with FabH. In silica ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) evaluation also pointed out that these compounds are potential for druggability. Further, effective overall docking scores of all the compounds have been recorded, and docking simulation of compound 31 into E. coli FabH binding pocket has been conducted, where solid binding interactions has been identified. (C) 2019 Elsevier Masson SAS. All rights reserved.

Synthesis and antibacterial evaluation of novel Schiff's base derivatives of nitroimidazole nuclei as potent E. coli FabH inhibitors

Design, Synthesis, and Antibacterial Evaluation of New Schiff’s Base Derivatives Bearing Nitroimidazole and Pyrazole Nuclei As Potent E. Coli FabH Inhibitors

Synthesis, Antibacterial Activities and Molecular Docking Studies of Schiff Bases Derived from N-(2/4-Benzaldehyde-Amino)Phenyl-N '-Phenyl-thiourea

Design, Synthesis and Antimicrobial Activities Evaluation of Schiff Base Derived from Secnidazole Derivatives As Potential FabH Inhibitors.

Novel Schiff-base-derived FabH inhibitors with dioxygenated rings as antibiotic agents.

Synthesis, molecular modeling and biological evaluation of β-ketoacyl-acyl carrier protein synthase III (FabH) as novel antibacterial agents

Novel Aminopyrimidinyl Benzimidazoles As Potentially Antimicrobial Agents: Design, Synthesis and Biological Evaluation

Design, Synthesis and Antibacterial Activities of 5-(Pyrazin-2-yl)-4h-1,2,4-triazole-3-thiol Derivatives Containing Schiff Base Formation As FabH Inhibitory.

Design and Synthesis of Potent Inhibitors of Beta-Ketoacyl-acyl Carrier Protein Synthase III (fabh) As Potential Antibacterial Agents.

Discovery of Natural Berberine-Derived Nitroimidazoles As Potentially Multi-Targeting Agents Against Drug-Resistant Escherichia Coli

Design, Synthesis and Biological Evaluation of Novel Thiazole Derivatives As Potent FabH Inhibitors

Design and synthesis of 2-styryl of 5-Nitroimidazole derivatives and antimicrobial activities as FabH inhibitors.

Design, Synthesis and Molecular Docking of 1,3,4-Oxadiazole-2(3H)-thione Derivatives Containing 1,4-Benzodioxane Skeleton as Potential FabH Inhibitors

Design and Synthesis of Thiazole Derivatives As Potent FabH Inhibitors with Antibacterial Activity.

Discovery of Novel Bacterial FabH Inhibitors (Pyrazol-Benzimidazole Amide Derivatives): Design, Synthesis, Bioassay, Molecular Docking and Crystal Structure Determination

Potentiating 1-(2-hydroxypropyl)-2-styryl-5-nitroimidazole derivatives against antibacterial agents: design, synthesis and biology analysis.

Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors.

Design, Synthesis and Antimicrobial Activities of Nitroimidazole Derivatives Containing 1,3,4-Oxadiazole Scaffold As Fabh Inhibitors

Study of Schiff-Base-Derived with Dioxygenated Rings and Nitrogen Heterocycle As Potential Β-Ketoacyl-acyl Carrier Protein Synthase III (fabh) Inhibitors.

Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors.

Design, Synthesis and Molecular Docking of Novel Bipyrazolyl Thiazolone Scaffold As a New Class of Antibacterial Agents